iPSC-derived models and New Approach Methodologies (NAMs)
Preview text: iPSC-derived models and New Approach Methodologies (NAMs) 96 We’ve launched our latest…
Image not available
No image available for this email.
- Subject
- iPSC-derived models and New Approach Methodologies (NAMs)
- Preview text
- iPSC-derived models and New Approach Methodologies (NAMs) 96 We’ve launched our latest…
- From
- marketing@
axolbio.com - Brand
- Axol Bioscience
- ESP
- HubSpot
- Sent
- Fri May 29, 2026, 2:48 PM ET
- Sent to
- axolbio.com
- Size
- 119 KB
- Images
- 9
- Links
- 13, 7 of them buttons
- Subject length
- 57 characters
Against Axol Bioscience's usual
Sent in its busiest hour, 2 PM, which holds 50% of its emails. The subject is 57 characters, the same as its average.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Axol Bioscience <[email protected]>
- Reply-To
- [email protected]
- Subject
- iPSC-derived models and New Approach Methodologies (NAMs)
- Date
- Fri, 29 May 2026 19:48:53 +0100
- Message-ID domain
- bf06x.hubspotemail.net
- Return-Path domain
- bf06x.hubspotemail.net
- DKIM signature
- d=bf06x.hubspotemail.net s=hs1; d=axolbio.com s=hs2-6097189
- Authentication
- dkim=pass (bf06x.hubspotemail.net), dkim=pass (axolbio.com), spf=pass (bf06x.hubspotemail.net), dmarc=pass (axolbio.com)
- List-Unsubscribe
- Present, one-click
- Feedback-ID sender
- HubSpot
Servers it passed through, newest first
- from bid47w8.bf06x.hubspotemail.net [158.247.24.202] by our receiving server with ESMTPS
Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To
Sent just before and after
| Jul 11, 2026 12:54 PM | Thank you for subscribing | |
| Jul 2, 2026 2:33 PM | Physiologically relevant human iPSC-derived models and specialist services | |
| Jul 2, 2026 2:16 PM | Thank you for subscribing | |
| Jun 29, 2026 8:30 AM | Physiologically relevant human iPSC-derived models | |
| May 29, 2026 2:48 PM | iPSC-derived models and New Approach Methodologies (NAMs) (this email) | |
| Apr 30, 2026 2:01 PM | Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug discovery | |
| Apr 17, 2026 8:31 AM | Thank you for subscribing |